rs747799506
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BA1BP4BS2_SupportingBP5
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Val966Ile variant in CDKL5 is 0.03% in South Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Val966Ile variant is observed in at least 1 unaffected individual (internal database) (BS2_supporting). Computational analysis prediction tools suggest that the p.Val966Ile variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Val966Ile variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Val966Ile variant in CDKL5 is classified as benign based on the ACMG/AMP criteria applied (BA1, BS2_supporting, BP4, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA209185/MONDO:0100039/016
Frequency
Consequence
NM_003159.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112374Hom.: 0 Cov.: 24 AF XY: 0.0000290 AC XY: 1AN XY: 34520
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183481Hom.: 0 AF XY: 0.0000589 AC XY: 4AN XY: 67911
GnomAD4 exome AF: 0.0000464 AC: 51AN: 1098012Hom.: 0 Cov.: 30 AF XY: 0.0000605 AC XY: 22AN XY: 363382
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112374Hom.: 0 Cov.: 24 AF XY: 0.0000290 AC XY: 1AN XY: 34520
ClinVar
Submissions by phenotype
CDKL5 disorder Benign:2
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). -
The allele frequency of the p.Val966Ile variant in CDKL5 is 0.03% in South Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Val966Ile variant is observed in at least 1 unaffected individual (internal database) (BS2_supporting). Computational analysis prediction tools suggest that the p.Val966Ile variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Val966Ile variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Val966Ile variant in CDKL5 is classified as benign based on the ACMG/AMP criteria applied (BA1, BS2_supporting, BP4, BP5). -
not specified Benign:1
- -
Developmental and epileptic encephalopathy, 2 Benign:1
- -
not provided Benign:1
This variant is associated with the following publications: (PMID: 23756444, 23242510) -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at